TY - JOUR
AU - T. S. Bartholomew
AU - H. E. Tookes
AU - T. A. Chueng
AU - R. N. Bluthenthal
AU - L. D. Wenger
AU - A. H. Kral
AU - B. H. Lambdin
A1 - 
AD - University of Miami, 1120 NW 14th St #860, Miami, FL, 33136, USA.; University of Miami, 1120 NW 14th St #860, Miami, FL, 33136, USA. hetookes@miami.edu.; University of Southern California, Los Angeles, CA, USA.; RTI International, Berkeley, CA, USA.
AN - 37660029
BT - Harm Reduct J
C5 - Opioids & Substance Use; HIT & Telehealth; Healthcare Disparities
CP - 1
DA - Sep 2
DO - 10.1186/s12954-023-00861-3
DP - NLM
ET - 20230902
IS - 1
JF - Harm Reduct J
LA - eng
PY - 2023
SN - 1477-7517
SP - 122
ST - Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency
T1 - Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency
T2 - Harm Reduct J
TI - Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency
U1 - Opioids & Substance Use; HIT & Telehealth; Healthcare Disparities
U3 - 10.1186/s12954-023-00861-3
VL - 20
VO - 1477-7517
Y1 - 2023
ER -